Balázs Babarczy

Balázs Babarczy

Auto-generated profile, based on publicly available information

Balázs Babarczy

Semmelweis Egyetem Egészségügyi Technológiaértékelő és Elemzési Központ, Budapest; Syreon Kutató Intézet, Budapest

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2025 in The European Journal of Health Economics
Verified
Journal Article
Open access
PDF file
MMMaureen Rutten-van Mölken
Maureen Rutten-van Mölken
HWHolly Whiteley
Holly Whiteley
BBBalázs Babarczy
Balázs Babarczy
JDJacob Davies
Jacob Davies
LGLucas Goossens
Lucas Goossens
RERhiannon Tudor Edwards
Rhiannon Tudor Edwards
Background Smart Capacitating Investments (SCI) have been proposed as a means of mobilizing extra public and private investments in health promotion and disease prevention, but the concept needs clarification and development. Aim To develop the concept SCI and explore available and emerging SCI models that could generate additional resources for health promotion and prevention. Methods i) a rapid scoping review to explore existing examples of innovative investment in health promotion and disease prevention, ii) horizon scanning of recent/emerging examples of innovative investment models via expert interviews and web searches, and iii) a realist-informed synthesis of literature and interview-results to investigate investor motivations, barriers, and enablers for different forms of SCI. Results We present a definition of SCI that stresses these unconventional investments are either financial or non-financial, that they are made by reallocating and pooling public funds within the health sector or by involving other non-health public sectors, private not-for-profit or for-profit social impact investors. SCI models aim to sustainably enhance individual and community capacity for healthier behaviors, or to address determinants of health. We describe the broad range and nature of SCI via a classification and typology of SCI models. Social Impact Bonds were found to be the most frequently applied model across all levels of prevention. For successful implementation of blended SCI models by public–private partnerships, significant government involvement was important. Conclusion SCIs are diverse and novel, and they have potential to bring about change, particularly if backed by government to attract private capital and ensure rigorous evaluation.

10 May 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
BBBalázs Babarczy
Balázs Babarczy
ÁHÁgnes Hajdu
Ágnes Hajdu
RBRia Benko
Ria Benko
MMMária Matuz
Mária Matuz
RPRenáta Papp
Renáta Papp
SWSahil Khan Warsi
Sahil Khan Warsi
Objectives Inappropriate antibiotic prescribing is a major cause of antimicrobial resistance (AMR). The aim of this study was to explore paediatric general practitioners’ (GP Peds) antibiotic prescription practice in suspected respiratory tract infections (RTIs), using the capability–opportunity–motivation–behaviour framework. Design The design is a qualitative study based on individual, semistructured telephone or virtual interviews. Setting Paediatric general practice in Hungary. We applied stratified maximum variation sampling to cover the categories of age, sex and geographical location of participants. Participants We interviewed 22 GP Peds. Nine were male and 13 were female: 2 of them were less than 40 years old, 14 were between 40 and 60 years, and 6 were above 60 years. 10 worked in low-antibiotic prescription areas, 5 in areas with medium levels of antibiotic prescription, 3 in high-antibiotic prescription areas, and 4 in and around the capital city. Results Study participants had varying antibiotic prescription preferences. Personal experience and physical examination play a central role in GP Peds’ diagnostic and treatment practice. Participants emphasised the need to treat children in their entirety, taking their personal medical record, social background and sometimes parents’ preferences into account, besides the acute clinical manifestation of RTI. Most respondents were confident they apply the most effective therapy even if, in some cases, this meant prescribing medicines with a higher chance of contributing to the development of AMR. Some participants felt antibiotic prescription frequency has decreased in recent years. Conclusions Our findings suggest that a more prudent attitude toward antibiotic prescribing may have become more common but also highlight relevant gaps in both physicians’ and public knowledge of antibiotics and AMR. To reinforce awareness and close remaining gaps, Hungary should adopt its national AMR National Action Plan and further increase its efforts towards active professional communication and feedback for primary care physicians.

7 September 2026 in Multidiszciplináris Egészség és Jóllét
Verified
Journal Article
Open access
PDF file
BBBalázs Babarczy
Balázs Babarczy
Az SCI modellek közép-európai alkalmazását nehezíti a legtöbb modellhez szükséges nonprofit vagy társadalmi elkötelezettségű befektetői ökoszisztéma fejletlensége. Ugyanakkor hatékony kormányzati koordináció mellett ezek a megoldások szolgáltatói oldalról segíthetnek a különböző állami szektorok közötti együttműködés elmélyítésében, illetve a civil szféra és a szélesebb társadalom intenzívebb bevonásába az egészségfejlesztési és betegségmegelőzési programokba. Ezen túlmenően a koncepció segít a prevenció befektetési értelmezésének hangsúlyozásában, a pusztán kiadási szemlélet helyett.

13 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Attila ImreAttila Imre
Attila Imre
ÁMÁgota Mészáros
Ágota Mészáros
BNBertalan Nemeth
Bertalan Nemeth
BNBalázs Nagy
Balázs Nagy
JHJudit Hagymásy
Judit Hagymásy
BBBalázs Babarczy
Balázs Babarczy
Background: Existing studies on the economic impact of schizophrenia are fragmented and vary in methodology, hindering an ample understanding of the total economic burden. Aims: To quantify the global economic burden of schizophrenia by synthesizing findings from systematic reviews and meta-analyses, and to assess variations by cost category, world region and income level. Method: We conducted a protocol-driven umbrella review registered on PROSPERO (CRD42024504092). A systematic search of MEDLINE, EMBASE, Cochrane Library, and APA PsycINFO identified reviews reporting annual per-patient monetary cost estimates for schizophrenia. Monetary values were adjusted for inflation and converted to 2024 US dollars. Results: Twenty-six systematic reviews involving 152 primary studies were included. The median annual per-patient total cost of schizophrenia was $33,236 (mean $47,872), with direct costs accounting for $23,126 (medical: $19,543; ancillary: $1,152) and indirect costs for $21,333. Costs were varied by income level: in high-income countries, the median total cost was $34,175, compared to $3,345 in upper-middle-income and $3,452 in lower-middle-income countries. Regional disparities were substantial, with Europe & Central Asia reporting the highest median costs among high-income settings. Data from low- and middle-income regions were limited or absent. Methodological heterogeneity, lack of standardization in cost reporting, and underrepresentation of low-resource settings limit generalizability. Conclusions: Schizophrenia poses a significant and unequally distributed global economic burden, driven by hospitalization, long-term care, and productivity losses. To support equitable policy and resource allocation, future research must adopt standardized costing frameworks and expand data collection into low-resource and understudied regions.